Correlation Between Bloomage Biotechnology and Shenzhen Mindray

Can any of the company-specific risk be diversified away by investing in both Bloomage Biotechnology and Shenzhen Mindray at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bloomage Biotechnology and Shenzhen Mindray into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bloomage Biotechnology Corp and Shenzhen Mindray Bio Medical, you can compare the effects of market volatilities on Bloomage Biotechnology and Shenzhen Mindray and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bloomage Biotechnology with a short position of Shenzhen Mindray. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bloomage Biotechnology and Shenzhen Mindray.

Diversification Opportunities for Bloomage Biotechnology and Shenzhen Mindray

0.96

Correlation Coefficient

Bloomage Biotechnology  Shenzhen Mindray

Almost no diversification

The 3 months correlation between Bloomage and Shenzhen is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Bloomage Biotechnology Corp and Shenzhen Mindray Bio Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Mindray Bio and Bloomage Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bloomage Biotechnology Corp are associated (or correlated) with Shenzhen Mindray. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Mindray Bio has no effect on the direction of Bloomage Biotechnology i.e., Bloomage Biotechnology and Shenzhen Mindray go up and down completely randomly.

Pair Corralation between Bloomage Biotechnology and Shenzhen Mindray

Assuming the 90 days trading horizon Bloomage Biotechnology Corp is expected to generate 1.24 times more return on investment than Shenzhen Mindray. However, Bloomage Biotechnology is 1.24 times more volatile than Shenzhen Mindray Bio Medical. It trades about -0.07 of its potential returns per unit of risk. Shenzhen Mindray Bio Medical is currently generating about -0.13 per unit of risk. If you would invest  5,943  in Bloomage Biotechnology Corp on September 19, 2024 and sell it today you would lose (256.00) from holding Bloomage Biotechnology Corp or give up 4.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Bloomage Biotechnology Corp  vs.  Shenzhen Mindray Bio Medical

Bloomage Biotechnology

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bloomage Biotechnology Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bloomage Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Mindray Bio

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Mindray Bio Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Mindray sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bloomage Biotechnology and Shenzhen Mindray

The main advantage of trading using opposite Bloomage Biotechnology and Shenzhen Mindray positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bloomage Biotechnology position performs unexpectedly, Shenzhen Mindray can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Mindray will offset losses from the drop in Shenzhen Mindray's long position.

The idea behind Bloomage Biotechnology Corp and Shenzhen Mindray Bio Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.